BioSpace News Archive

Press Releases

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

June 18, 2026
·
4 min read
Press Releases

Legend Biotech Corporation Announces Pricing of Public Offering - June 17, 2026

June 18, 2026
·
4 min read
Press Releases

FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma

June 18, 2026
·
11 min read
Press Releases

F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis

June 18, 2026
·
9 min read
Press Releases

LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody

June 18, 2026
·
3 min read
Press Releases

AI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech’s Zabopegdutide in Phase 2 MASH Trial

June 18, 2026
·
5 min read
Press Releases

WuXi Biologics’ Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market

June 18, 2026
·
4 min read
Press Releases

Kardigan Announces Pricing of Upsized Initial Public Offering

June 18, 2026
·
4 min read
Press Releases

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

June 18, 2026
·
7 min read
Press Releases

Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery

June 18, 2026
·
2 min read